Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05610839 · ClinicalTrials.gov registry record · NA

A RCT of a Fully-automated Self-help AEBT Website

A NA study of AEBT Website With Check-ins and AEBT Website Without Check-ins, sponsored by Utah State University.

Completed
Registry status
NA
Development phase
101
Enrollment target
1
Study location

NCT05610839: Completed NA study of AEBT Website With Check-ins and AEBT Website Without Check-ins, sponsored by Utah State University.

NCT05610839 is a NA study of AEBT Website With Check-ins and AEBT Website Without Check-ins that has completed, run by Utah State University. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05610839, a NA study of AEBT Website With Check-ins and AEBT Website Without Check-ins, has completed, sponsored by Utah State University.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target
1
Study location

Study Summary

Trichotillomania (TTM) is characterized by hair pulling that is repetitive in nature leading to notable hair loss, causing clinically significant distress and resulting in impairments across social and functional domains (APA, 2013). Trichotillomania causes significant social impairment including affecting close relationships, pursuing occupational changes or advancement, or interfering with schooling (Grant et al., 2017; Woods, Flessner, Franklin, Wetterneck, et al., 2006). The core of the treatment of trichotillomania has traditionally been Habit Reversal Training (HRT) (Twohig, Bluett, et al., 2014). Another form of treatment that is gaining empirical support is Acceptance and Commitment Therapy (ACT) which has been studied in four randomized controlled trials, one studying ACT as a standalone treatment (Lee, Homan, et al., 2018), and three examining ACT combined with HRT (Twohig et al., 2021; Lee, Haeger, et al., 2018; Woods, Wetterneck, et al., 2006) which demonstrated efficacy of the combined treatment in decreasing pulling symptom severity. The prevalence of trichotillomania in the US is 1-2% of the population and yet treatment access is limited by many issues including processionals' lack of knowledge of the disorder and low treatment accessibility (Walther et al., 2010). ACT- enhanced behavior therapy has been implemented using telehealth to reach a larger population (42.2% decrease pre-to-post treatment), but telehealth still requires therapist time and incurs notable costs (Lee, Haeger, et al., 2018). The present study aims to address the gap in trichotillomania treatment accessibility by examining the role of check-ins on adherence and efficacy on afully automated, web-based ACT-enhanced HRT treatment for adults with trichotillomania across the United States. We predict that the condition with check-ins will increase adherence and efficacy of the treatment significantly more than the condition without check-ins. Additionally, we predict that hair pullin

Primary Outcome

The MGH-HPS assesses urges to pull, pulling behavior, and the distress caused by pulling through a seven-item self-report measure. Items are rated individually on a scale from 0-4 and then the total scale is summed from 0-28-point total score. Higher scores indicate greater hair pulling severity. Treatment response is indicated by a seven-point reduction in score (Houghton et al., 2015). The MGH-HPS demonstrates good internal consistency (Keuthen et al., 1995), test-retest reliability and conver

Interventions

  • BEHAVIORAL Acceptance-Enhanced Behavior Therapy

Study Locations (1)

Utah

  • Utah State University - Logan

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2022-11-08
Est. Completion 2023-09-29
Phase NA
Utah State University

27 total trials

What the finished NCT05610839 record still lists

NCT05610839 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 2 conditions, with AEBT Website With Check-ins appearing as the primary indexed condition, and to 1 intervention - of which Acceptance-Enhanced Behavior Therapy is the first listed.

NCT05610839 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT05610839 about?

NCT05610839 is a clinical study titled "A RCT of a Fully-automated Self-help AEBT Website". Trichotillomania (TTM) is characterized by hair pulling that is repetitive in nature leading to notable hair loss, causing clinically significant distress and resulting in impairments across social and functional domains (APA, 2013). Trichotillomania causes significant social impairment including af...

What is the current status of trial NCT05610839?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2022-11-08. Estimated completion is 2023-09-29.

What conditions does trial NCT05610839 study?

This clinical trial studies the following conditions: AEBT Website With Check-ins, AEBT Website Without Check-ins.

What interventions are being tested in trial NCT05610839?

The interventions under investigation include: Acceptance-Enhanced Behavior Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05610839?

This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05610839 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT05610839's enrollment target sits among peer trials

101 840th of 2000 higher than 1,161 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04033497 · 101 participants · NA

    Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

  • NCT05111574 · 101 participants · Phase 2

    Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

  • NCT05984680 · 101 participants

    COPD Care Pathway Among Patients With Cancer

  • NCT06266299 · 101 participants · Phase 1

    A Study of KK2269 in Adult Participants With Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05610839, the US trial registry maintained by the National Library of Medicine. NCT05610839 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.